http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019216874-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a049ac63e17b57ec0c2902c5b3bec1ec |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-48 |
| filingDate | 2018-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a49244d32f68ee886115d128714c98a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0653c0ba8a269e90d33f211038072bc |
| publicationDate | 2019-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2019216874-A1 |
| titleOfInvention | COMMON BEAN (PHASEOLUS VULGARIS) EXTRACT WITH HIGH a-AMYLASE INHIBITORY ACTIVITY AND LOW HEMAGGLUTININ ACTIVITY |
| abstract | An improved method for making a p. vulgaris bean extract that results in an extract having high α-amylase inhibitory activity and low hemagglutinin activity. The method involves treating the beans to selectively denature the hemagglutinin. A p. vulgaris bean extract is provided, having high α-amylase inhibitory activity and low hemagglutinin activity. A treatment for diabetes or method for reducing blood glucose level is disclosed using the p. vulgaris bean extract disclosed herein. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111560057-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112898397-A |
| priorityDate | 2018-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.